These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 35528236)
21. A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients. Chen M; Nie Z; Li Y; Gao Y; Wen X; Cao H; Zhang S Front Cell Dev Biol; 2021; 9():699804. PubMed ID: 34869304 [No Abstract] [Full Text] [Related]
22. A novel prognostic model associated with the overall survival in patients with breast cancer based on lipid metabolism-related long noncoding RNAs. Shi GJ; Zhou Q; Zhu Q; Wang L; Jiang GQ J Clin Lab Anal; 2022 Jun; 36(6):e24384. PubMed ID: 35441740 [TBL] [Abstract][Full Text] [Related]
23. A Novel Pyroptosis-Associated Long Non-coding RNA Signature Predicts Prognosis and Tumor Immune Microenvironment of Patients With Breast Cancer. Ping L; Zhang K; Ou X; Qiu X; Xiao X Front Cell Dev Biol; 2021; 9():727183. PubMed ID: 34616734 [No Abstract] [Full Text] [Related]
24. Bioinformatics analysis of necroptosis‑related lncRNAs and immune infiltration, and prediction of the prognosis of patients with esophageal carcinoma. Duan X; Du H; Yuan M; Liu L; Liu R; Shi J Exp Ther Med; 2023 Jul; 26(1):331. PubMed ID: 37346407 [TBL] [Abstract][Full Text] [Related]
25. A long non-coding RNAs expression signature to improve prognostic prediction of Wilms tumor in children. Zhao H; Wang P; Wang G; Zhang S; Guo F Transl Pediatr; 2021 Mar; 10(3):525-540. PubMed ID: 33850811 [TBL] [Abstract][Full Text] [Related]
26. N7-methylguanosine-related lncRNAs: Predicting the prognosis and diagnosis of colorectal cancer in the cold and hot tumors. Wu JY; Song QY; Huang CZ; Shao Y; Wang ZL; Zhang HQ; Fu Z Front Genet; 2022; 13():952836. PubMed ID: 35937987 [No Abstract] [Full Text] [Related]
27. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma. Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566 [TBL] [Abstract][Full Text] [Related]
28. A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer. Zhang K; Ping L; Du T; Liang G; Huang Y; Li Z; Deng R; Tang J Front Mol Biosci; 2021; 8():678877. PubMed ID: 34164433 [No Abstract] [Full Text] [Related]
29. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. Fan CN; Ma L; Liu N J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893 [TBL] [Abstract][Full Text] [Related]
30. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma. Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203 [TBL] [Abstract][Full Text] [Related]
31. Development of a novel five-lncRNA prognostic signature for predicting overall survival in elderly patients with breast cancer. Luo Y; Zhang Y; Wu YX; Li HB; Shen D; Che YQ J Clin Lab Anal; 2022 Jan; 36(1):e24172. PubMed ID: 34894405 [TBL] [Abstract][Full Text] [Related]
32. Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma. Huang J; Xu Z; Teh BM; Zhou C; Yuan Z; Shi Y; Shen Y J Clin Lab Anal; 2022 Jun; 36(6):e24480. PubMed ID: 35522142 [TBL] [Abstract][Full Text] [Related]
33. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer. Peng Y; Wang H; Huang Q; Wu J; Zhang M J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063 [TBL] [Abstract][Full Text] [Related]
34. Recognition of Glycometabolism-Associated lncRNAs as Prognosis Markers for Bladder Cancer by an Innovative Prediction Model. Tang D; Li Y; Tang Y; Zheng H; Luo W; Li Y; Li Y; Wang Z; Wu S Front Genet; 2022; 13():918705. PubMed ID: 35928440 [TBL] [Abstract][Full Text] [Related]
35. A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast Cancer. Zhang X; Zhang X; Li G; Hao Y; Liu L; Zhang L; Chen Y; Wu J; Wang X; Yang S; Xu S J Immunol Res; 2022; 2022():3143511. PubMed ID: 35578667 [TBL] [Abstract][Full Text] [Related]
36. A Novel Model Based on Genomic Instability-Associated Long Non-Coding RNAs for Predicting Prognosis and Response to Immunotherapy in Patients With Lung Adenocarcinoma. Tu G; Peng W; Cai Q; Zhao Z; Peng X; He B; Zhang P; Shi S; Wang X Front Genet; 2021; 12():720013. PubMed ID: 34777461 [No Abstract] [Full Text] [Related]
37. Identification of a Novel Glycolysis-Related LncRNA Signature for Predicting Overall Survival in Patients With Bladder Cancer. Zheng Z; Lai C; Li W; Zhang C; Ma K; Yao Y Front Genet; 2021; 12():720421. PubMed ID: 34490046 [TBL] [Abstract][Full Text] [Related]
38. Prognostic Value of N6-Methyladenosine-Related lncRNAs in Early-Stage Colorectal Cancer: Association With Immune Cell Infiltration and Chemotherapeutic Drug Sensitivity. Xiong Z; Li X; Yin S; Xie M; Mao C; Zhang F; Chen H; Jin L; Lian L Front Mol Biosci; 2021; 8():724889. PubMed ID: 34712696 [No Abstract] [Full Text] [Related]
39. Necroptosis-associated long noncoding RNAs can predict prognosis and differentiate between cold and hot tumors in ovarian cancer. He YB; Fang LW; Hu D; Chen SL; Shen SY; Chen KL; Mu J; Li JY; Zhang H; Yong-Lin L; Zhang L Front Oncol; 2022; 12():967207. PubMed ID: 35965557 [TBL] [Abstract][Full Text] [Related]
40. A Novel Framework to Predict Breast Cancer Prognosis Using Immune-Associated LncRNAs. Huang Z; Xiao C; Zhang F; Zhou Z; Yu L; Ye C; Huang W; Li N Front Genet; 2020; 11():634195. PubMed ID: 33584821 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]